report
Women’s health rehabilitation products market to hit $9.68b by 2034
Women’s health rehabilitation products market to hit $9.68b by 2034
By application, the “Hospitals” segment is expected to dominate the sector.
7MM Parkinson’s disease market to be valued at $7b by 2033
Eight late-stage pipeline products are expected to launch during the forecast period.
Global liquid biopsy market to hit $7.05b by 2030
Tech advancements like next-generation sequencing drive the sector.
Brachytherapy devices market to reach $534.2m by 2031
By application, the prostate cancer segment dominated in 2024.
Trust in doctors crucial for AI acceptance in Australian healthcare
The majority were comfortable receiving AI information from their doctor.
Emerging markets to see mixed health spending growth
India and Turkiye are experiencing sharp increases in expenditure.
Patient data hub solutions market to be valued at $3.01b by 2033
Thanks to a rising need for centralised data and interoperability.
Blood platelets market to hit $4b by 2030
Thanks to its use in regenerative medicine and biotechnology.
Medical device market on track for mid-single digit growth
The sector is seeing mixed growth across categories.
Diagnostics M&A activity to stay subdued in H2 amidst tariff uncertainty
Deal volume slowed after the first quarter.
Global suppositories market to hit $2.05b by 2030
Its expansion is driven by increasing cases of digestive diseases.
Surgical sutures market to be valued at $6.65b by 2030
Thanks to a rise in surgical interventions driven by an ageing population.
7MM hidradenitis suppurativa market to quadruple by 2034
Thanks to the approval and uptake of next-generation biologics.
7MM treatment-resistant hypertension market to grow 5% annually until 2034
Better diagnostic practices and combination therapy developments drive the sector.
APAC to see highest growth in global medical displays market
Thanks to increased investments and an ageing population.
7MM triple-negative breast cancer market eyes 4.7% CAGR growth until 2034
The sector’s expansion is attributed to rising incidence rates.
Biologic therapeutic market to hit $794.5b by 2029
Thanks to the demand for monoclonal antibodies, gene and cell therapies, and vaccines.